The pill showed "significant" reductions in airway obstruction after 26 weeks. The first oral pill for obstructive sleep apnea (OSA) could be around the corner after pharmaceutical company Apnimed Inc ...
Yaqoot Fatima receives funding from NHMRC, MRFF, Beyond Blue and in-kind support from ResMed. Nisreen Aouira does not work for, consult, own shares in or receive funding from any company or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback